Avian influenza vaccination in Egypt: Limitations of the current strategy.
about
The emergence and diversification of panzootic H5N1 influenza virusesAn overview of the epidemic of highly pathogenic H5N1 avian influenza virus in Egypt: epidemiology and control challenges.Acquisition of human-type receptor binding specificity by new H5N1 influenza virus sublineages during their emergence in birds in Egypt.Antigenic and genetic evolution of low-pathogenicity avian influenza viruses of subtype H7N3 following heterologous vaccination.Visualization of Alternative Functional Configurations of Influenza Virus Hemagglutinin Facilitates Rapid Selection of Complementing Vaccines in Emergency SituationsPuzzling inefficiency of H5N1 influenza vaccines in Egyptian poultryIdentifying live bird markets with the potential to act as reservoirs of avian influenza A (H5N1) virus: a survey in northern Viet Nam and Cambodia.Antigenic characterization of recent H5N1 highly pathogenic avian influenza viruses circulating in Egyptian poultryImmunogenicity and efficacy of fowlpox-vectored and inactivated avian influenza vaccines alone or in a prime-boost schedule in chickens with maternal antibodies.Impact of the implementation of rest days in live bird markets on the dynamics of H5N1 highly pathogenic avian influenza.Antigenic drift in H5N1 avian influenza virus in poultry is driven by mutations in major antigenic sites of the hemagglutinin molecule analogous to those for human influenza virusHighly pathogenic avian influenza virus subtype H5N1 escaping neutralization: more than HA variation.Protective Efficacy of Recombinant Turkey Herpes Virus (rHVT-H5) and Inactivated H5N1 Vaccines in Commercial Mulard Ducks against the Highly Pathogenic Avian Influenza (HPAI) H5N1 Clade 2.2.1 Virus.Poultry rearing and slaughtering practices in rural Egypt: an exploration of risk factors for H5N1 virus human transmissionAvian influenza vaccination of poultry and passive case reporting, Egypt.Role of vaccination-induced immunity and antigenic distance in the transmission dynamics of highly pathogenic avian influenza H5N1Avian Influenza A(H5N1) Virus in EgyptA single amino acid at the hemagglutinin cleavage site contributes to the pathogenicity but not the transmission of Egyptian highly pathogenic H5N1 influenza virus in chickens.Interventions for avian influenza A (H5N1) risk management in live bird market networks.Modelling influenza A H5N1 vaccination strategy scenarios in the household poultry sector in Egypt.Intervention strategies to reduce the risk of zoonotic infection with avian influenza viruses: scientific basis, challenges and knowledge gaps.Avian influenza from an ecohealth perspective.Protection conferred by recombinant turkey herpesvirus avian influenza (rHVT-H5) vaccine in the rearing period in two commercial layer chicken breeds in Egypt.Comparison of the effectiveness of rHVT-H5, inactivated H5 and rHVT-H5 with inactivated H5 prime/boost vaccination regimes in commercial broiler chickens carrying MDAs against HPAI H5N1 clade 2.2.1 virus.H9N2 influenza A virus circulates in H5N1 endemically infected poultry population in Egypt.Outbreaks of H5N1 in poultry in Thailand: the relative role of poultry production types in sustaining transmission and the impact of active surveillance in control.Public health concerns of highly pathogenic avian influenza H5N1 endemicity in Africa.Predicting risk of avian influenza a(H5N1) in Egypt: the creation of a community level metric.Avian influenza A (H5N1) outbreaks in different poultry farm types in Egypt: the effect of vaccination, closing status and farm size.Creating Disease Resistant Chickens: A Viable Solution to Avian Influenza?
P2860
Q28292060-EAE08B76-1A47-4679-878C-8BF1A59B85B6Q30399136-65809C92-3330-44E4-BD14-FC1C214BA06CQ30403405-27D5A3E1-A1D0-41EB-AA2F-5A8341C47EFAQ33601920-445692A2-CB11-4FAD-9F6F-06F6CC7CD6A7Q33624535-7B05F494-412A-48A8-B959-0D2F2FAF5C45Q33934663-457B6785-76B0-4670-A422-4CBDE6DE057CQ34295661-2E69AA87-FFFE-476C-935D-E6271AD1DC0DQ34466534-C0BD006B-C497-453D-994F-89349B157537Q34643285-8F12C1D9-1BD5-40DA-8110-B62AFE098E50Q35059336-1885EC15-6678-4AD1-8625-56B0C7AF0BF5Q35192981-15643188-100C-4B93-AE0E-02BAF40BDB1AQ35689647-9D6B4AA2-AB88-4F95-9E9D-955C01BB02C9Q36052756-8404BF15-475A-4F22-B3CB-8611B5A880C3Q36251593-4A9443B6-2688-4350-8784-6F26AFE382A9Q36570496-6D5E714F-0D6E-4857-83E6-61A0844EDB3FQ36596186-21077F53-B53E-4C92-8E7E-856F14A1743AQ36617093-A18EB50A-6F8C-4B71-A94F-E53D3E3353BAQ36760101-62BC63C0-9ACD-4702-B48F-82B9764D5C5BQ36895848-45CA8E16-7735-47FF-A315-72C0ECDF3D5EQ37491281-55721F51-886E-46C7-98D9-137E8EA03B22Q38137378-1FA38810-BF80-4FF7-A29C-1152BF7515DAQ38206966-4D4769CA-C3C7-410E-9C10-1B844B8E2CCFQ39124967-58985F54-9986-460E-8FF7-CA9C4EE9CAD7Q39135857-54894A7E-AED9-470B-B3ED-ABBD6355ADE2Q39263210-6D96A8B2-32CB-4A43-905E-624D65C316D4Q42082558-B0AD8D3D-7491-4CE3-A2E0-FD839F7C86D9Q47139864-4989F97E-4ECF-4FD5-9887-C26E6AD6A649Q51783261-99D5B1D4-1F2A-4F91-9526-DC2352D87F77Q55347106-06889107-A725-4B6E-9A57-1C8C7D2BAAD3Q57466490-DD4AFA12-45D8-4426-AFE3-328D1457A619
P2860
Avian influenza vaccination in Egypt: Limitations of the current strategy.
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Avian influenza vaccination in Egypt: Limitations of the current strategy.
@ast
Avian influenza vaccination in Egypt: Limitations of the current strategy.
@en
Avian influenza vaccination in Egypt: Limitations of the current strategy.
@nl
type
label
Avian influenza vaccination in Egypt: Limitations of the current strategy.
@ast
Avian influenza vaccination in Egypt: Limitations of the current strategy.
@en
Avian influenza vaccination in Egypt: Limitations of the current strategy.
@nl
prefLabel
Avian influenza vaccination in Egypt: Limitations of the current strategy.
@ast
Avian influenza vaccination in Egypt: Limitations of the current strategy.
@en
Avian influenza vaccination in Egypt: Limitations of the current strategy.
@nl
P2093
P2860
P1476
Avian influenza vaccination in Egypt: Limitations of the current strategy.
@en
P2093
Ahmed Saad
Amira Abd-Elnabi
François Roger
Gwenaelle Dauphin
Hamid Samaha
Joseph Domenech
Juan Lubroth
Marisa Peyre
Saber Galal
Toni Ettel
P2860
P304
P356
10.4172/1747-0862.1000035
P577
2009-12-09T00:00:00Z